Secondary analysis of BEST-CLI (1,017 patients): 76.5% reported meaningful 1-year improvement in vascular quality of life regardless of revascularisation type; cardiometabolic risk factors and higher baseline status predicted no improvement.
Secondary analysisn = 1,017
Smolderen et al. Predictors of Clinically Meaningful 1-Year Health Status Improvements Following Endovascular or Surgical Revascularization: Insights From the BEST-CLI Trial